99%+ Purity
COA Included
Sealed Vials
CJC-1295 (No DAC)
GHRH analog for pulsatile GH release
GH pulses
Key Benefits
- Preserves natural pulsatile GH release patterns
- May support healthy IGF-1 production
- Works with body's circadian rhythms
- Supports physiological hormone balance
- May enhance protein synthesis processes
- Maintains natural growth hormone physiology
- Short half-life prevents receptor desensitization
Want to purchase this peptide?
Your Body's Natural Growth Signal—Without the Crash
Most growth hormone approaches flood your system continuously, which actually backfires by desensitizing receptors and disrupting natural rhythms. CJC-1295 (No DAC) works with your body's existing pulse patterns instead of against them. You get the recovery, body composition, and energy benefits without throwing your hormonal balance into chaos.
Pituitary GHRH receptor activation / Natural pulsatile growth hormone release pathway
About CJC-1295 (No DAC)
CJC-1295 (No DAC) is a synthetic growth hormone-releasing hormone analog that triggers your pituitary to release GH in natural pulses rather than constant elevation. Unlike longer-acting versions, it preserves your body's circadian rhythm and prevents receptor burnout. This approach maintains the physiological balance needed for sustainable results in recovery, body composition, and metabolic health.
Who It's For
Ideal for individuals seeking growth hormone benefits without disrupting natural hormonal patterns or risking long-term receptor desensitization. This peptide fits well into protocols focused on optimizing recovery, body composition, and metabolic function while maintaining hormonal balance. The short half-life makes it particularly valuable for those who want to work with their body's existing rhythms rather than override them completely.
Research Background
CJC-1295 represents an advancement in growth hormone-releasing hormone (GHRH) analog development, specifically designed to address limitations of natural GHRH's short half-life. The peptide works by binding to specific GHRH receptors in the pituitary gland, triggering a cascade of cellular events that ultimately leads to growth hormone secretion. Research has identified two distinct versions: the DAC (Drug Affinity Complex) version and the no-DAC version, each with unique pharmacological profiles and potential applications.
The primary research focus centers on understanding how these two versions differ in their ability to maintain physiological GH pulsatility. The no-DAC version preserves the body's natural pulsatile GH release pattern, which is crucial for optimal metabolic function and minimizing side effects. This pulsatile pattern is important because continuous GH exposure can lead to receptor desensitization and metabolic complications. Current research directions include: 1) Optimizing dosing protocols to maximize benefits while maintaining safety, 2) Investigating therapeutic applications in age-related GH decline and muscle wasting conditions, and 3) Understanding long-term effects on body composition, bone health, and metabolic parameters.
Dosing Protocol
| Level | Dose | |
|---|---|---|
Beginner | 200 mcg | |
Intermediate | 300 mcg | |
Advanced | 250 mcg 2x/day | |
Maximum | 250-500 mg 2-3x/day |
Select a dosing level and click Calculate to plan your protocol.
Vials Required
2
18.0 mg needed ÷ 10 per vial
Total Investment
$140
$70.00 per vial
Per Dose
0.06 mL
6 units on U-100 syringe
Doses per Vial
33
10 ÷ 0.30 mg/dose
* Calculations based on standard reconstitution protocols. Consult research guidelines for specific applications.
Educational Resources
Download educational materials and research documentation for CJC-1295 (No DAC).
Featured in These Stacks
GH Axis Bundel
GH Axis Inventory
The GH Axis Inventory is the primary performance multiplier inside the peptide model. Growth hormone signaling influences body composition, tissue repair, recovery bandwidth, and metabolic responsiveness. Without this axis, fat loss becomes muscle loss, recovery slows, and training output plateaus. This inventory is intentionally layered to provide flexibility across intensity levels: Sermorelin serves as entry-level endogenous stimulation. Tesamorelin (10mg & 20mg) targets visceral fat and provides scalable leverage. Tesamorelin / Ipamorelin blends amplify GH pulses for structured recomposition. Tesamorelin / CJC / Ipamorelin creates triple-pathway synergy. CJC-1295 (DAC & No DAC) allows duration control — pulse vs sustained. Ipamorelin provides clean adjunct stimulation. IGF-1 LR3 delivers downstream growth expression. Fragment 176-191 targets fat mobilization pathways. This layered approach prevents over-reliance on a single compound and allows protocols to adapt to client progression. As volume increases, GH flexibility becomes revenue protection — because it prevents stagnation. Strategically, the GH axis: Enhances recomposition efficiency Preserves lean mass during fat loss Accelerates recovery Supports connective tissue repair Increases training capacity At scale, GH inventory becomes a central profit driver. It supports both base stacks and premium builds. It is not optional — it is structural. This is not a single product category. It is a signaling architecture built to scale results.
Includes
Compliance & Disclaimer
This product is intended for laboratory research purposes only. Not for human consumption. All products are sold with the understanding that the purchaser will comply with all applicable local, state, and federal laws regarding the purchase and use of research chemicals. Certificate of Analysis available upon request.
Related Products
CJC-1295 / Ipamorelin
CJC-1295 and Ipamorelin are designed for clients who want measurable performance, recovery, and longevity benefits—without crossing the line into hormone replacement or system shutdown. This is not synthetic HGH and it’s not a short-term hack. It’s a disciplined, physiology-first approach that restores the body’s own growth hormone signaling, which naturally declines with age, stress, poor sleep, and overtraining. CJC-1295 works upstream at the pituitary level, enhancing the quality, duration, and consistency of natural GH release, while Ipamorelin acts as a precision trigger—stimulating GH without the cortisol spikes, prolactin elevation, or hunger issues associated with older compounds. Together, they create smoother, more youthful GH pulses that the body actually knows how to use. From a client experience standpoint, this shows up where it matters: deeper, more restorative sleep; faster recovery between workouts or long workdays; improved fat metabolism; better skin and tissue quality; and a noticeable improvement in overall resilience. There’s no suppression of natural production, no dependency risk, and no hormonal rollercoaster—making it appropriate for long-term use and scalable protocols. For many clients, this stack becomes the foundation layer they build everything else on, because it improves how the body repairs, adapts, and recovers across the board. In short, this is growth hormone optimization for adults who play the long game—subtle, sustainable, and designed to deliver compounding returns over time.
Tesamorelin
GHRH analog for visceral fat reduction
Retatrutide
Triple agonist (GLP-1/GIP/Glucagon) for aggressive fat loss
SS-31
Mitochondrial-targeted peptide for cellular repair
MOTS-c
Mitochondrial peptide for metabolic regulation